Which hematopoietic stem cell transplantation type is safe for patients with hepatitis B virus carriers.

被引:0
|
作者
Üstün, C
Idilman, R
Özcan, M
Akan, H
Karayalcin, S
Gürman, G
Ilhan, O
Beksac, M
Uysal, A
Konuk, N
Demirer, T
Koc, H
机构
[1] Ankara Univ, Dept Gastroenterol, TR-06100 Ankara, Turkey
[2] Ankara Univ, Dept Hematol, TR-06100 Ankara, Turkey
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
2221
引用
收藏
页码:718A / 718A
页数:1
相关论文
共 50 条
  • [41] Hepatitis B Virus Vaccination after Allogeneic Hematopoietic Cell Transplantation Prevents Post-Transplantation Hepatitis B Virus Reactivation
    Hammond, Sarah P.
    Ho, Vincent T.
    Marty, Francisco M.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (07): : 402.e1 - 402.e5
  • [42] Prevalence and clinical consequences of Hepatitis C virus infection in patients undergoing hematopoietic stem cell transplantation
    Diaz, Ana Claudia Marques Barbosa
    Witkin, Steven Sol
    de Almeida-Neto, Cesar
    Mendrone-Junior, Alfredo
    Rocha, Vanderson
    Costa, Silvia Figueiredo
    Ramos, Jessica Fernandes
    Mendes-Correa, Maria Cassia
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2024, 66
  • [43] Hematopoietic stem cell transplantation for patients with mucopolysaccharidosis type II
    Kubaski, Francyne
    Suzuki, Yasuyuki
    Yabe, Hiromasa
    Mason, Robert W.
    Xie, Li
    Onsten, Tor G. H.
    Leistner-Segal, Sandra
    Giugliani, Roberto
    Dung, Vu C.
    Ngoc, Can T. B.
    Ngoc, Can T. B.
    Yamaguchi, Seiji
    Montano, Adriana M.
    Orii, Kenji E.
    Fukao, Toshiyuki
    Shinataku, Haruo
    Orii, Tadao
    Tomatsu, Shunji
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S77 - S77
  • [44] A PROSPECTIVE MULTICENTER TRIAL OF VACCINATION TO PREVENT HEPATITIS B VIRUS REACTIVATION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Nishikawa, Koji
    Kimura, Kiminori
    Sugiyama, Masaya
    Bae, Sung Kwan
    Ishikawa, Tetsuya
    Inoue, Kazuaki
    Saito, Hidetugu
    Kanto, Tatsuya
    Mizokami, Masashi
    HEPATOLOGY, 2019, 70 : 581A - 582A
  • [45] Hepatitis B virus reactivation recurred after the cessation of entecavir in an allogenetic hematopoietic stem cell transplantation patient
    Wang, Qing
    Xu, Zhi-Qiang
    Fu, Juan-Juan
    Pan, Xiu-Cheng
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2017, 41 (04) : E48 - E50
  • [46] Resolved Hepatitis B Virus Infection Is Not Associated with Worse Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
    Ramos, Carlos A.
    Saliba, Rima M.
    Silva, Leandro de Padua
    Khorshid, Ola
    Shpall, Elizabeth J.
    Giralt, Sergio
    Patah, Poliana A.
    Hosing, Chitra M.
    Popat, Uday R.
    Rondon, Gabriela
    Nieto, Yago
    Champlin, Richard E.
    de Lima, Marcos
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (05) : 686 - 694
  • [47] Colistin is relatively safe in hematological malignancies and hematopoietic stem cell transplantation patients
    D. Averbuch
    E. Horwitz
    J. Strahilevitz
    P. Stepensky
    N. Goldschmidt
    M. E. Gatt
    M. Y. Shapira
    I. B. Resnick
    D. Engelhard
    Infection, 2013, 41 : 991 - 997
  • [48] Colistin is relatively safe in hematological malignancies and hematopoietic stem cell transplantation patients
    Averbuch, D.
    Horwitz, E.
    Strahilevitz, J.
    Stepensky, P.
    Goldschmidt, N.
    Gatt, M. E.
    Shapira, M. Y.
    Resnick, I. B.
    Engelhard, D.
    INFECTION, 2013, 41 (05) : 991 - 997
  • [49] Hepatitis B virus infection status is an independent risk factor for multiple myeloma patients after autologous hematopoietic stem cell transplantation
    Li, Juan
    Liu, Junru
    Huang, Beihui
    Zheng, Dong
    Chen, Mei
    Zhou, Zhenhai
    Xu, Duorong
    Zou, Waiyi
    TUMOR BIOLOGY, 2013, 34 (03) : 1723 - 1728
  • [50] Epstein-Barr virus reactivation correlates with worse outcomes for patients exposed to hepatitis B virus after haploidentical hematopoietic stem cell transplantation
    Hu, Jiajia
    Zhao, Jie
    Wang, Chunyan
    Jia, Mei
    Su, Ming
    Li, Shanshan
    ANNALS OF HEMATOLOGY, 2023, 102 (12) : 3593 - 3601